This page provides details about the portfolio of CanTest projects. In order to form part of the programme, projects must be approved via a two-stage scientific peer review process. This includes assessment against the following principles:
- The current diagnostic process in primary care is a problem
- Improving the triaging and diagnostic process related to (1) may have value to patients and society by having a potential impact on the morbidity, mortality, patient experience or healthcare utilisation of patients with and without cancer
- There is at least promising evidence from Phase 1 or later phases of the CanTest Framework, or research from other settings
- The diagnostic process is potentially feasible in community or primary care settings
Below you can find out more information about our current projects:
The clinical utility, feasibility and acceptability of a genomic test to target bowel cancer screening
This PhD project seeks to answer questions of clinical utility, feasibility and acceptability of risk stratified population colorectal cancer screening guided by a lifestyle or genomic risk model delivered in general practice.
Risk of lung cancer in symptomatic patients with negative chest x-ray results
This project will generate a tool that will estimate positive predictive values for lung cancer in smokers and non-smokers who have negative chest x-ray results in combination with particular symptoms.
Development of a primary care head and neck risk assessment tool
This study will investigate how GPs feel about RATs that are currently in use and what their views on a new tool to help with referrals for suspected head and neck cancer.
Diagnostic processes and use of investigations before a cancer diagnosis in patients with comorbidities
This project aims to generate evidence for optimising diagnostic strategies in patients with comorbidities experiencing possible cancer symptoms, in order to improve diagnostic timeliness.
Exploring patient, practitioner and general population preferences towards diagnostic tests for cancer
This PhD project will develop a set of choice based experiments to explore the preferences of patients, practitioners and the general public towards different diagnostic test strategies and to assess the risk-benefit trade-offs.
Direct access to fast transvaginal ultrasound for earlier diagnosis of ovarian cancer
Denmark based study on access of transvaginal ultrasound through general practice to improve prognosis for ovarian cancer.
Guideline discordant diagnostic care: when do referrals not reflect guidelines for suspected cancer?
This study will look at how often GPs follow the guidelines and whether certain types of patients or patients with certain symptoms are more or less likely to be urgently referred when the guidelines suggest they should be.
Melanoma risk assessment and tailored prevention in general practice
This PhD will be the first series of studies in Australia to test and measure the acceptability and usefulness of skin self-monitoring apps for melanoma from a patient perspective.
Are patients with high-normal platelet counts at increased risk of cancer?
Our previous work found that cancer risk was greatly increased for people with clinically high platelets (cells in the blood that enable clotting). The NORMA study will investigate whether people with platelet counts at the high end of the normal range are also at increased risk of cancer.
Aids to cancer diagnosis in primary care
This study is part of a wider Health and Technology Assessment study whose overall aim is to understand the effectiveness, cost-effectiveness and current use of cancer diagnostic tools to aid decision-making in primary care.